← All Conditions ← Urinary Overview

Polycystic Kidney Disease (PKD)

★ CMTO Exam Focus

A hereditary disorder characterized by progressive development and enlargement of multiple fluid-filled cysts within the kidneys, gradually replacing functional renal parenchyma. Autosomal dominant PKD (ADPKD) is the most common form, affecting approximately 1 in 400-1,000 people worldwide. Mutations in PKD1 (85%) or PKD2 genes impair polycystin proteins that regulate tubular epithelial cell growth and fluid secretion. ADPKD typically becomes symptomatic in the 3rd-4th decade of life, with approximately 50% of patients reaching end-stage renal disease by age 60. Critical extrarenal complications include intracranial aneurysms (approximately 8% of ADPKD patients).

Recognition

  • Flank or back pain: From cyst enlargement, hemorrhage into a cyst, or concurrent nephrolithiasis
  • Hypertension: The most common early manifestation — occurs in 60-70% of patients before significant renal function decline
  • Hematuria: Gross or microscopic blood in urine from cyst rupture
  • Recurrent UTIs and pyelonephritis: Cysts provide a protected environment for bacterial growth
  • Abdominal fullness and palpable kidneys: Kidneys become massively enlarged in advanced disease
  • Progressive CKD: Renal function declines over decades. Staging and management follow CKD guidelines
  • Headache: May indicate intracranial aneurysm — "thunderclap headache" (sudden, severe, worst headache of life) suggests subarachnoid hemorrhage
  • Extrarenal manifestations: Hepatic cysts, pancreatic cysts, mitral valve prolapse, aortic root aneurysm

MT Relevance

  • Avoid direct pressure over the kidneys (posterior flank, approximately L1 level) in patients with known large cysts — cyst rupture, while unusual, can cause severe pain and internal bleeding
  • Hypertension management: Very common in PKD. Follow hypertension precautions — lighter pressure, slow repositioning, monitor for orthostatic hypotension (antihypertensive medications)
  • When renal function is impaired: Apply all CKD considerations — tissue fragility, anemia, fluid retention, platelet dysfunction, medication complexity
  • Dialysis clients: Avoid the ipsilateral arm with AV fistula or graft. Treat on non-dialysis days
  • Intracranial aneurysm awareness: If suspected rupture (sudden severe headache, stiff neck, photophobia, altered consciousness) — immediately cease treatment and call 911
  • General massage is appropriate for compensated, medically managed PKD with no active complications

Required Actions

  • Thunderclap headache (sudden, severe, worst headache of life) in a client with known PKD: Call 911 immediately — possible subarachnoid hemorrhage from intracranial aneurysm
  • Bilateral palpable flank masses in an undiagnosed client: Document and refer for medical evaluation
  • New gross hematuria or severe flank pain: Refer — possible cyst hemorrhage or rupture

Key Takeaways

  • PKD is a hereditary condition causing progressive bilateral kidney cyst growth with eventual CKD in approximately 50% of ADPKD patients by age 60
  • Avoid direct posterior flank pressure over the kidneys in advanced disease where cysts are large
  • Intracranial aneurysm is present in approximately 8% of ADPKD patients — thunderclap headache is a medical emergency
  • Hypertension is the earliest and most common manifestation — manage as per CKD guidelines once renal function declines
  • General massage is safe in compensated, medically managed PKD

Sources

  • Werner, R. (2019). A massage therapist's guide to pathology (7th ed.). Books of Discovery.
  • Norris, T. L. (2019). Porth's essentials of pathophysiology (5th ed.). Wolters Kluwer.
  • Tortora, G. J., & Derrickson, B. H. (2021). Principles of anatomy and physiology (16th ed.). Wiley.
  • Rattray, F., & Ludwig, L. (2000). Clinical massage therapy: Understanding, assessing and treating over 70 conditions. Talus Incorporated.